Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Compounds with the ability to activate nicotinic acetylcholine receptors described by Suntory

Dec. 21, 2001

Diazabicyclic compounds modulate acetylcholine receptors to induce analgesia

Dec. 21, 2001

Pagoclone shows promising results in treatment of generalized anxiety disorder

Dec. 21, 2001

Aradigm completes phase IIb trials of AERx Pain Management System

Dec. 21, 2001

Synaptic files IND application for antidepressant drug

Dec. 21, 2001

Initiation of phase III trials of Antegren in multiple sclerosis and Crohn's disease

Dec. 21, 2001

NMDA receptor antagonists and their use disclosed by Roche

Dec. 20, 2001

U.S. patent covers Guilford's metabotropic glutamate receptor ligands and their use

Dec. 19, 2001

Synthesis and use of cyclohexylamine series of NMDA receptor antagonists

Dec. 19, 2001

FDA approval extends Paxil's indications to include posttraumatic stress disorder

Dec. 19, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...